Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
The Intervention Group
The Control Group
Locations
1
United States
MD Anderson Cancer Center
Houston, Texas, United States
Start Date
June 6, 2022
Primary Completion Date
May 10, 2024
Completion Date
May 10, 2024
Last Updated
October 23, 2024
NCT06346132
NCT07482709
NCT07351968
NCT06946290
NCT07041736
NCT07473635
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions